A large analysis of two major clinical trials has found that the spread of prostate cancer can be detected on imaging scans even when biomarkers remain stable in patients treated with androgen receptor inhibitors, according to the study published in the Journal of Clinical Oncology.
This article was originally published on MedicalXpress.com

